Labetuzumab (Anti-CEACAM5 / CEA / CD66e)Labetuzumab (Anti-CEACAM5 / CEA / CD66e)
Move your mouse over image or click to enlarge

Labetuzumab (Anti-CEACAM5 / CEA / CD66e)

Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.
Cat# Size Price Qty Buy
A2638-1mg*25 1mg*25
£3,415.00
A2638-1mg*5 1mg*5
£1,138.00
A2638-1mg 1mg
£384.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2638

Related Documents